November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Study Finds High Prevalence of Medication-Induced Movement Disorders in Psychiatric Patients

🧠 Mind & Mental Health 2 min read 👁 2

A new study reveals that nearly 39% of psychiatric patients receiving regular follow-up care at an Ethiopian hospital experienced psychotropic medication-induced movement disorders.

🧠Mind & Mental Health

Key points

  • Prevalence of movement disorders reached 38.6% among psychiatric outpatients.
  • First- and second-generation antipsychotics were linked to higher odds of symptoms.
  • Longer illness duration and schizophrenia diagnosis increased risk.

Researchers investigating adverse effects in psychiatric care found that psychotropic medication-induced movement disorders affect more than one-third of patients undergoing regular follow-up. Conducted at the University of Gondar Hospital between October 1 and November 30, 2025, the institution-based cross-sectional study utilized the Extrapyramidal Symptom Rating Scale to assess participants selected through systematic random sampling. The overall prevalence of these movement disorders was identified at 38.6%.

The observational investigation highlights several factors linked to higher odds of developing these involuntary movements. Researchers noted that patients taking first-generation antipsychotics or second-generation antipsychotics faced significantly greater odds of movement disorders compared to those using antidepressants. Additionally, longer illness durations exceeding 10 years, a formal diagnosis of schizophrenia, and being single were associated with increased risk.

Because this was an observational cross-sectional study, it points to correlations rather than direct causation, and findings may reflect specific regional clinical populations. Authors emphasize that these adverse effects can cause substantial patient distress, stigma, and reduced medication adherence, meaning they require careful, routine clinical monitoring.

What to know: Over 38% of patients in the study experienced movement side effects linked to psychiatric medications, particularly antipsychotics and long-standing schizophrenia diagnoses. Always consult a qualified healthcare provider regarding personal treatment decisions and medication management.

Source Nature Health Sciences — nature.com/articles/s41598-026-78102-3 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.